Grace Therapeutics, Inc. Annual General and Administrative Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Grace Therapeutics, Inc. quarterly/annual General and Administrative Expense history and growth rate from 2018 to 2023.
  • Grace Therapeutics, Inc. General and Administrative Expense for the quarter ending December 31, 2024 was $1.51M, a 5.63% decline year-over-year.
  • Grace Therapeutics, Inc. General and Administrative Expense for the twelve months ending December 31, 2024 was $6.95M, a 7.78% decline year-over-year.
  • Grace Therapeutics, Inc. annual General and Administrative Expense for 2023 was $6.43M, a 15.5% decline from 2022.
  • Grace Therapeutics, Inc. annual General and Administrative Expense for 2022 was $7.61M, a 17.8% decline from 2021.
  • Grace Therapeutics, Inc. annual General and Administrative Expense for 2021 was $9.26M, a 67.8% increase from 2020.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.